Clinical Trial (CTMS) Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251505 | Category: Service & Software | Pages: 107 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial (CTMS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial (CTMS). This report contains market size and forecasts of Clinical Trial (CTMS) in global, including the following market information:
Global Clinical Trial (CTMS) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Trial (CTMS) market was valued at US$ 48020 million in 2022 and is projected to reach US$ 63030 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Trial (CTMS) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Trial (CTMS) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trial (CTMS) Market Segment Percentages, by Type, 2022 (%)
    Enterprise CTMS
    Site CTMS
Global Clinical Trial (CTMS) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trial (CTMS) Market Segment Percentages, by Application, 2022 (%)
    Pharma & Biopharmaceutical Companies
    Clinical Research Organizations
    Others
Global Clinical Trial (CTMS) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Clinical Trial (CTMS) Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Trial (CTMS) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Trial (CTMS) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Oracle
    Medidata Solutions
    PAREXEL
    IBM
    ERT
    Bioclinica
    Forte Research Systems
    Veeva Systems
    MasterControl
    MedNet Solutions
    DSG
    Bio-Optronics
    DATATRAK
    DZS Software Solutions
    ArisGlobal
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Trial (CTMS), market overview.
Chapter 2: Global Clinical Trial (CTMS) market size in revenue.
Chapter 3: Detailed analysis of Clinical Trial (CTMS) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Trial (CTMS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Clinical Trial (CTMS) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Clinical Trial (CTMS) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Clinical Trial (CTMS) Overall Market Size
    2.1 Global Clinical Trial (CTMS) Market Size: 2022 VS 2029
    2.2 Global Clinical Trial (CTMS) Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Clinical Trial (CTMS) Players in Global Market
    3.2 Top Global Clinical Trial (CTMS) Companies Ranked by Revenue
    3.3 Global Clinical Trial (CTMS) Revenue by Companies
    3.4 Top 3 and Top 5 Clinical Trial (CTMS) Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Clinical Trial (CTMS) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Clinical Trial (CTMS) Players in Global Market
        3.6.1 List of Global Tier 1 Clinical Trial (CTMS) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Clinical Trial (CTMS) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Clinical Trial (CTMS) Market Size Markets, 2022 & 2029
        4.1.2 Enterprise CTMS
        4.1.3 Site CTMS
    4.2 By Type - Global Clinical Trial (CTMS) Revenue & Forecasts
        4.2.1 By Type - Global Clinical Trial (CTMS) Revenue, 2018-2023
        4.2.2 By Type - Global Clinical Trial (CTMS) Revenue, 2024-2029
        4.2.3 By Type - Global Clinical Trial (CTMS) Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Clinical Trial (CTMS) Market Size, 2022 & 2029
        5.1.2 Pharma & Biopharmaceutical Companies
        5.1.3 Clinical Research Organizations
        5.1.4 Others
    5.2 By Application - Global Clinical Trial (CTMS) Revenue & Forecasts
        5.2.1 By Application - Global Clinical Trial (CTMS) Revenue, 2018-2023
        5.2.2 By Application - Global Clinical Trial (CTMS) Revenue, 2024-2029
        5.2.3 By Application - Global Clinical Trial (CTMS) Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Clinical Trial (CTMS) Market Size, 2022 & 2029
    6.2 By Region - Global Clinical Trial (CTMS) Revenue & Forecasts
        6.2.1 By Region - Global Clinical Trial (CTMS) Revenue, 2018-2023
        6.2.2 By Region - Global Clinical Trial (CTMS) Revenue, 2024-2029
        6.2.3 By Region - Global Clinical Trial (CTMS) Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Clinical Trial (CTMS) Revenue, 2018-2029
        6.3.2 US Clinical Trial (CTMS) Market Size, 2018-2029
        6.3.3 Canada Clinical Trial (CTMS) Market Size, 2018-2029
        6.3.4 Mexico Clinical Trial (CTMS) Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Clinical Trial (CTMS) Revenue, 2018-2029
        6.4.2 Germany Clinical Trial (CTMS) Market Size, 2018-2029
        6.4.3 France Clinical Trial (CTMS) Market Size, 2018-2029
        6.4.4 U.K. Clinical Trial (CTMS) Market Size, 2018-2029
        6.4.5 Italy Clinical Trial (CTMS) Market Size, 2018-2029
        6.4.6 Russia Clinical Trial (CTMS) Market Size, 2018-2029
        6.4.7 Nordic Countries Clinical Trial (CTMS) Market Size, 2018-2029
        6.4.8 Benelux Clinical Trial (CTMS) Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Clinical Trial (CTMS) Revenue, 2018-2029
        6.5.2 China Clinical Trial (CTMS) Market Size, 2018-2029
        6.5.3 Japan Clinical Trial (CTMS) Market Size, 2018-2029
        6.5.4 South Korea Clinical Trial (CTMS) Market Size, 2018-2029
        6.5.5 Southeast Asia Clinical Trial (CTMS) Market Size, 2018-2029
        6.5.6 India Clinical Trial (CTMS) Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Clinical Trial (CTMS) Revenue, 2018-2029
        6.6.2 Brazil Clinical Trial (CTMS) Market Size, 2018-2029
        6.6.3 Argentina Clinical Trial (CTMS) Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Clinical Trial (CTMS) Revenue, 2018-2029
        6.7.2 Turkey Clinical Trial (CTMS) Market Size, 2018-2029
        6.7.3 Israel Clinical Trial (CTMS) Market Size, 2018-2029
        6.7.4 Saudi Arabia Clinical Trial (CTMS) Market Size, 2018-2029
        6.7.5 UAE Clinical Trial (CTMS) Market Size, 2018-2029
7 Clinical Trial (CTMS) Companies Profiles
    7.1 Oracle
        7.1.1 Oracle Company Summary
        7.1.2 Oracle Business Overview
        7.1.3 Oracle Clinical Trial (CTMS) Major Product Offerings
        7.1.4 Oracle Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.1.5 Oracle Key News & Latest Developments
    7.2 Medidata Solutions
        7.2.1 Medidata Solutions Company Summary
        7.2.2 Medidata Solutions Business Overview
        7.2.3 Medidata Solutions Clinical Trial (CTMS) Major Product Offerings
        7.2.4 Medidata Solutions Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.2.5 Medidata Solutions Key News & Latest Developments
    7.3 PAREXEL
        7.3.1 PAREXEL Company Summary
        7.3.2 PAREXEL Business Overview
        7.3.3 PAREXEL Clinical Trial (CTMS) Major Product Offerings
        7.3.4 PAREXEL Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.3.5 PAREXEL Key News & Latest Developments
    7.4 IBM
        7.4.1 IBM Company Summary
        7.4.2 IBM Business Overview
        7.4.3 IBM Clinical Trial (CTMS) Major Product Offerings
        7.4.4 IBM Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.4.5 IBM Key News & Latest Developments
    7.5 ERT
        7.5.1 ERT Company Summary
        7.5.2 ERT Business Overview
        7.5.3 ERT Clinical Trial (CTMS) Major Product Offerings
        7.5.4 ERT Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.5.5 ERT Key News & Latest Developments
    7.6 Bioclinica
        7.6.1 Bioclinica Company Summary
        7.6.2 Bioclinica Business Overview
        7.6.3 Bioclinica Clinical Trial (CTMS) Major Product Offerings
        7.6.4 Bioclinica Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.6.5 Bioclinica Key News & Latest Developments
    7.7 Forte Research Systems
        7.7.1 Forte Research Systems Company Summary
        7.7.2 Forte Research Systems Business Overview
        7.7.3 Forte Research Systems Clinical Trial (CTMS) Major Product Offerings
        7.7.4 Forte Research Systems Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.7.5 Forte Research Systems Key News & Latest Developments
    7.8 Veeva Systems
        7.8.1 Veeva Systems Company Summary
        7.8.2 Veeva Systems Business Overview
        7.8.3 Veeva Systems Clinical Trial (CTMS) Major Product Offerings
        7.8.4 Veeva Systems Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.8.5 Veeva Systems Key News & Latest Developments
    7.9 MasterControl
        7.9.1 MasterControl Company Summary
        7.9.2 MasterControl Business Overview
        7.9.3 MasterControl Clinical Trial (CTMS) Major Product Offerings
        7.9.4 MasterControl Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.9.5 MasterControl Key News & Latest Developments
    7.10 MedNet Solutions
        7.10.1 MedNet Solutions Company Summary
        7.10.2 MedNet Solutions Business Overview
        7.10.3 MedNet Solutions Clinical Trial (CTMS) Major Product Offerings
        7.10.4 MedNet Solutions Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.10.5 MedNet Solutions Key News & Latest Developments
    7.11 DSG
        7.11.1 DSG Company Summary
        7.11.2 DSG Business Overview
        7.11.3 DSG Clinical Trial (CTMS) Major Product Offerings
        7.11.4 DSG Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.11.5 DSG Key News & Latest Developments
    7.12 Bio-Optronics
        7.12.1 Bio-Optronics Company Summary
        7.12.2 Bio-Optronics Business Overview
        7.12.3 Bio-Optronics Clinical Trial (CTMS) Major Product Offerings
        7.12.4 Bio-Optronics Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.12.5 Bio-Optronics Key News & Latest Developments
    7.13 DATATRAK
        7.13.1 DATATRAK Company Summary
        7.13.2 DATATRAK Business Overview
        7.13.3 DATATRAK Clinical Trial (CTMS) Major Product Offerings
        7.13.4 DATATRAK Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.13.5 DATATRAK Key News & Latest Developments
    7.14 DZS Software Solutions
        7.14.1 DZS Software Solutions Company Summary
        7.14.2 DZS Software Solutions Business Overview
        7.14.3 DZS Software Solutions Clinical Trial (CTMS) Major Product Offerings
        7.14.4 DZS Software Solutions Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.14.5 DZS Software Solutions Key News & Latest Developments
    7.15 ArisGlobal
        7.15.1 ArisGlobal Company Summary
        7.15.2 ArisGlobal Business Overview
        7.15.3 ArisGlobal Clinical Trial (CTMS) Major Product Offerings
        7.15.4 ArisGlobal Clinical Trial (CTMS) Revenue in Global Market (2018-2023)
        7.15.5 ArisGlobal Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Clinical Trial (CTMS) Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?